NEW YORK (GenomeWeb) – Belgian personalized cancer firm OncoDNA said today it has been awarded a contract to conduct testing and analysis for the Breast International Group (BIG), a Brussels non-profit that funds breast cancer research.

Under the multi-year contract, OncoDNA will perform its OncoDEEP Clinical Plus test on primary and metastatic tumor and blood samples from BIG's AURORA breast cancer clinical research program, which launched on April 15.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.